Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Home-Based Assessment of Patient Reported Outcome Measures Using a Smartphone App Platform: A Feasibility Study

Sherif M. Badawy, MD, Leonardo Barrera, MPH, Graham Zolkowski, BS, Zeinab Alward, MBChB, MPH

Blood (2019) 134 (Supplement_1): 420.

https://doi.org/10.1182/blood-2019-131334

Published: 2019

Journal Articles

Prognostic Effects of Pretreatment Statuses at Diagnosis in Patients with Chronic Myeloid Leukemia: Results of the New Target Observational Study 1

Takaaki ONO, MD PhD, Naoto Takahashi, MD PhD, Masahiro Kizaki, MD, Tatsuya Kawaguchi, MD, Ritsuro Suzuki, MD PhD, Kazuhito Yamamoto, Kazunori Ohnishi, MD, Tomoki Naoe, MD PhD, Itaru Matsumura, MD PhD

Blood (2019) 134 (Supplement_1): 4149.

https://doi.org/10.1182/blood-2019-122092

Published: 2019

Journal Articles

Erythropoietin Level and Percentage of Urinary Albumin Are Important for Renal Recovery in Patients with Multiple Myeloma Receiving Novel Agents

Hiroki Kobayashi, MD, Yoshiaki Abe, Daisuke Miura, MD, Kentaro Narita, MD, Akihiro Kitadate, MD PhD, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2018) 132 (Supplement 1): 5571.

https://doi.org/10.1182/blood-2018-99-110495

Published: 2018

Journal Articles

Clinical Features and Predictive Factors of Early Mortality in Patients with MM Outside of Clinical Trials

Hiroki Kobayashi, MD, Yoshiaki Abe, Daisuke Miura, MD, Kentaro Narita, MD, Akihiro Kitadate, MD PhD, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2018) 132 (Supplement 1): 5593.

https://doi.org/10.1182/blood-2018-99-113750

Published: 2018

Journal Articles

Use of Mobile Health (mHealth) Apps and Wearable Technology to Assess Changes in Pain during Treatment of Acute Pain in Sickle Cell Disease

Amanda Johnson, MD, Siddharth Gollarahalli, Daniel Abrams, Jude Jonassaint, Nirmish Shah, MD

Blood (2017) 130 (Supplement 1): 2230.

https://doi.org/10.1182/blood.V130.Suppl_1.2230.2230

Published: 2017

Journal Articles

Prognostic Significance of Medullary Abnormalities of the Appendicular Skeleton Detected By Low-Dose Whole-Body Multidetector Computed Tomography in Patients with Multiple Myeloma

Hiroki Kobayashi, MD, Yoshiaki Abe, Kentaro Narita, MD, Akihiro Kitadate, MD, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2017) 130 (Supplement 1): 1763.

https://doi.org/10.1182/blood.V130.Suppl_1.1763.1763

Published: 2017

Journal Articles

Long-Term Treatment with Imatinib Is Associated with Decreased Estimated Glomerular Filtration Rate and Hemoglobin Level in Patients with Chronic Myelogenous Leukemia

Masatoshi Sakurai, MD PhD, Takehiko Mori, MD PhD, Daiki Karigane, MD, Hidenori Kasahara, MD, Keiichi Tozawa, MD, Eri Matsuki, MD PhD MPH, Taku Kikuchi, MD, Jun Kato, MD, Takayuki Shimizu, MD PhD, Shinichiro Okamoto, MD PhD

Blood (2016) 128 (22): 1888.

https://doi.org/10.1182/blood.V128.22.1888.1888

Published: 2016

Journal Articles

Impact of Normalized Free Light Chain Ratio for Assessment of Monoclonal Protein in Patients with Light Chain Only and Oligosecretory Myeloma

Kentaro Narita, MD, Yoshiaki Usui, MD, Yoshiaki Abe, MD, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2016) 128 (22): 2074.

https://doi.org/10.1182/blood.V128.22.2074.2074

Published: 2016

Journal Articles

Oncoguide System- a Computerized Interactive Assistance System for the Diagnosis and Treatment of CML / MPN and MDS

Dirk Hempel, Prof.Dr.

Blood (2015) 126 (23): 5145.

https://doi.org/10.1182/blood.V126.23.5145.5145

Published: 2015

Journal Articles

Reversal of Renal Function and Its Prognostic Impact in Patients with Multiple Myeloma in the Era of Novel Agents

Kentaro Narita, Yoshiaki Usui, MD, Yasuhito Suehara, MD, Kota Fukumoto, MD, Manabu Fujisawa, MD, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2015) 126 (23): 3056.

https://doi.org/10.1182/blood.V126.23.3056.3056

Published: 2015

Journal Articles

Comparison of Outcomes after Double or Single-Unit Cord Blood Transplantation in Patients with Hematological Malignancies Using TBI-Containing Myeloablative Conditioning Regimen, a Retrospective Matched Control Study on Behalf of C-SHOT0507 and JSHCT Registry Data in Japan

Atsushi Wake, MD PhD, Shunro Kai, MD PhD, Masaya Okada, MD PhD, Koji Kato, MD, Naoyuki Uchida, MD PhD, Naoki Kobayashi, MDPhD, Nobuyuki Aotsuka, MD PhD, Jun Ishikawa, MD, Satoshi Takahashi, MD PhD, Tetsuya Eto, MD PhD, Shuichi Taniguchi, MD PhD, Yoshiko Atsuta, MDPhD, Shunichi Kato, MD PhD

Blood (2014) 124 (21): 2548.

https://doi.org/10.1182/blood.V124.21.2548.2548

Published: 2014

Journal Articles

9 Year Follow-up After Initial Treatment with FC and FCR Regimens In Chronoc Lymphocytic Leukemia - Impact of pretreatment CIRS

Elena Stadnik, Vladimir Strugov, Yulia Virts, Andrey Zaritskey

Blood (2011) 118 (21): 4616.

https://doi.org/10.1182/blood.V118.21.4616.4616

Published: 2011

Journal Articles

A Low-Cost, Open-Source Informatics Framework for Clinical Trials and Outcomes Research

William T. Tse, MD, PhD, Kevin K. Duh, Morris Kletzel, MD

Blood (2011) 118 (21): 4763.

https://doi.org/10.1182/blood.V118.21.4763.4763

Published: 2011

Journal Articles

Usability Testing of An Online Transition Program for Adolescents with Hemophilia

Vicky R. Breakey, BSc, MD, FRCPC, Ashley Warias, Danial M Ignas, BEng, Victor S. Blanchette, MD, FRCPC, Jennifer Stinson, BScN, PhD

Blood (2011) 118 (21): 4777.

https://doi.org/10.1182/blood.V118.21.4777.4777

Published: 2011

Journal Articles

Genome Redux for Hematologists: a Graphical User Interface for Visualizing and Reducing Genome-Wide Data Sets Into Clinically Actionable Information

Thomas Gage, M.D., Ali Kazeroonian, M.T., German A. Pihan, MD

Blood (2010) 116 (21): 2558.

https://doi.org/10.1182/blood.V116.21.2558.2558

Published: 2010

NARROW

Home-Based Assessment of Patient Reported Outcome Measures Using a Smartphone App Platform: A Feasibility Study

Prognostic Effects of Pretreatment Statuses at Diagnosis in Patients with Chronic Myeloid Leukemia: Results of the New Target Observational Study 1

Erythropoietin Level and Percentage of Urinary Albumin Are Important for Renal Recovery in Patients with Multiple Myeloma Receiving Novel Agents

Clinical Features and Predictive Factors of Early Mortality in Patients with MM Outside of Clinical Trials

Use of Mobile Health (mHealth) Apps and Wearable Technology to Assess Changes in Pain during Treatment of Acute Pain in Sickle Cell Disease

Prognostic Significance of Medullary Abnormalities of the Appendicular Skeleton Detected By Low-Dose Whole-Body Multidetector Computed Tomography in Patients with Multiple Myeloma

Long-Term Treatment with Imatinib Is Associated with Decreased Estimated Glomerular Filtration Rate and Hemoglobin Level in Patients with Chronic Myelogenous Leukemia

Impact of Normalized Free Light Chain Ratio for Assessment of Monoclonal Protein in Patients with Light Chain Only and Oligosecretory Myeloma

Oncoguide System- a Computerized Interactive Assistance System for the Diagnosis and Treatment of CML / MPN and MDS

Reversal of Renal Function and Its Prognostic Impact in Patients with Multiple Myeloma in the Era of Novel Agents

Comparison of Outcomes after Double or Single-Unit Cord Blood Transplantation in Patients with Hematological Malignancies Using TBI-Containing Myeloablative Conditioning Regimen, a Retrospective Matched Control Study on Behalf of C-SHOT0507 and JSHCT Registry Data in Japan

9 Year Follow-up After Initial Treatment with FC and FCR Regimens In Chronoc Lymphocytic Leukemia - Impact of pretreatment CIRS

A Low-Cost, Open-Source Informatics Framework for Clinical Trials and Outcomes Research

Usability Testing of An Online Transition Program for Adolescents with Hemophilia

Genome Redux for Hematologists: a Graphical User Interface for Visualizing and Reducing Genome-Wide Data Sets Into Clinically Actionable Information

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only